Suzanne Lentzsch

Columbia University Irving Medical Center

Also affiliated with Columbia College, Royal College of Physicians, Columbia University

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 15 papers. Top paper: “Use of daratumumab in high risk multiple myeloma: A meta‐analysis”.

Use of daratumumab in high risk multiple myeloma: A meta‐analysis

eJHaem(2020)10.1002/jha2.47

N/A

0.500DataRank · unranked

27 citations

Samuel Pan, Suzanne Lentzsch, Divaya Bhutani, Vikram Premkumar

Targeting the GCK pathway: a novel and selective therapeutic strategy against RAS-mutated multiple myeloma

Blood(2020)10.1182/blood.2020006334

N/A

0.442DataRank · unranked

18 citations

Jing Fu, Jun Yang, Huihui Ma, Divaya Bhutani, Markus Y. Mapara +3 more

Dual targeting of protein translation and nuclear protein export results in enhanced antimyeloma effects

Blood Advances(2023)10.1182/bloodadvances.2021006638

N/A

0.416DataRank · unranked

15 citations

Jing Fu, Christopher J. Walker, Jun Yang, Divaya Bhutani, Rajshekhar Chakraborty +5 more

GCK inhibition enhances iberdomide antimyeloma effects by promoting IKZF1 degradation via a CRBN-independent mechanism

Blood Neoplasia(2025)10.1016/j.bneo.2025.100130

N/A

0.104DataRank · unranked

1 citations

Josefine Krüger, Guifen Liu, Huihui Ma, Michael Sang Hughes, Rajshekhar Chakraborty +6 more

Gaps and opportunities in the treatment of relapsed-refractory multiple myeloma: Consensus recommendations of the NCI Multiple Myeloma Steering Committee

Blood Cancer Journal(2022)10.1038/s41408-022-00695-5

N/A

0DataRank · unranked

61 citations

Lawrence Baizer, Natalie S. Callander, Sergio Giralt, Jens Hillengaß, Boris Freidlin +11 more

IFN-γR/STAT1 signaling in recipient hematopoietic antigen-presenting cells suppresses graft-versus-host disease

Journal of Clinical Investigation(2022)10.1172/jci125986

N/A

0DataRank · unranked

18 citations

Huihui Ma, Liangsong Song, Hui Wang, Lily Wang, Shirong Li +8 more

Prevalence of Monoclonal Gammopathy of Undetermined Significance in Black South African Men

Cancer Epidemiology Biomarkers & Prevention(2022)10.1158/1055-9965.epi-22-0525

N/A

0DataRank · unranked

14 citations

Maureen Joffe, Moosa Patel, Codruța Chiuzan, Audrey Pentz, Paul Ruff +6 more

Prevalence of monoclonal gammopathy of undetermined significance in black South African men.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.e20032

N/A

0DataRank · unranked

0 citations

Maureen Joffe, Moosa Patel, Audrey Pentz, Paul Ruff, Suzanne Lentzsch +6 more

The checkpoint inhibitor PD-1H/VISTA controls osteoclast-mediated multiple myeloma bone disease

Nature Communications(2023)10.1038/s41467-023-39769-8

N/A

0DataRank · unranked

23 citations

Shirong Li, Huihui Ma, Jun Yang, Gabriel M. Pagnotti, Lewis M. Brown +4 more

Safety and Efficacy of SGLT2 Inhibitors for Amyloid Light-Chain Cardiomyopathy

Journal of Cardiac Failure(2024)10.1016/j.cardfail.2024.06.009

N/A

0DataRank · unranked

18 citations

Sergio Teruya, Margaret Cuomo, Alfonsina Mirabal Santos, Jai Radhakrishnan, Suzanne Lentzsch +4 more

Screening for Systemic Light-Chain Amyloidosis in Patients Over 60 with λ Monoclonal Gammopathies

Journal of Clinical Medicine(2025)10.3390/jcm14124146

N/A

0DataRank · unranked

1 citations

Mahesh Mansukhani, Raymond T. Yeh, Jiesheng Lu, Hongai Xia, Lahari Koganti +14 more

Proteinuria with preserved renal function (PPRF): A retrospective cohort study in newly diagnosed multiple myeloma.

Journal of Clinical Oncology(2025)10.1200/jco.2025.43.16_suppl.e19559

N/A

0DataRank · unranked

0 citations

Metodi Balev, Jai Radhakrishnan, Divaya Bhutani, Markus Y. Mapara, Suzanne Lentzsch +3 more

A phase 2 multicentre study of siltuximab, an anti-interleukin-6 monoclonal antibody, in patients with relapsed or refractory multiple myeloma

UNC Libraries(2020)10.17615/tmgg-w910

N/A

0DataRank · unranked

0 citations

Suzanne Lentzsch, Pieter Sonneveld, Sonja Zweegman, Hong Xie, Xiang Qin +13 more

Venetoclax induces deep hematologic remissions in t(11;14) relapsed/refractory AL amyloidosis

Blood Cancer Journal(2021)10.1038/s41408-020-00397-w

N/A

0DataRank · unranked

110 citations

Suzanne Lentzsch, Samuel Pan, Divaya Bhutani, Joshua Richter, Sundar Jagannath +13 more

Graded Cardiac Response Criteria for Patients With Systemic Light Chain Amyloidosis

Journal of Clinical Oncology(2022)10.1200/jco.22.00643

N/A

0DataRank · unranked

90 citations

Angela Dispenzieri, Brendan Wisniowski, Giovanni Palladini, Paolo Milani, Giampaolo merlini +22 more